WITI Hall of Fame

2017 Inductees


Beena Ammanath Beena Ammanath
Global VP - Artificial Intelligence/Data/Innovation, HPE

Laura Niklason, M.D., Ph.D. Laura Niklason, M.D., Ph.D.
Founder, Humacyte

Krunali Patel Krunali Patel
VP & GM of Analog Design Services, Texas Instruments

Lisa Seacat DeLuca Lisa Seacat DeLuca
Technology Strategist, Cognitive Incubation Lab, IBM Watson Customer Engagement

Selma Svendsen Selma Svendsen
Senior Director of Program Management, iRobot

Elizabeth Xu, Ph.D. Elizabeth Xu, Ph.D.
CTO & SVP of Technology, BMC Software



Previous Inductees


  2017

  2016

  2015

  2014

  2013

  2012

  2011

  2010

  2009

  2008

  2007

  2006

  2005

  2004

  2003

  2002

  2001

  2000

  1999

  1998

  1997

  1996

Featured Profile


Laura Niklason, M.D., Ph.D.

Laura Niklason, M.D., Ph.D.

Founder, Humacyte

Inducted in: 2017

Laura Niklason, founder of the regenerative medicine company Humacyte, has been a patient advocate and an inventor throughout the course of her career. She is the Nicholas M. Greene Professor in Anesthesia and Biomedical Engineering at Yale University, where she has been on faculty since 2006.

Her research focuses primarily on regenerative strategies for cardiovascular and lung tissues. Dr. Niklasonís bioengineered blood vessels are currently undergoing clinical trials, and are the first life-sustaining engineered tissues to be studied under a Phase III trial. Her lab was also one of the first to describe the engineering of whole lung tissue that could exchange gas in vivo, and her work was cited in 2010 as one of the top 50 most important inventions of the year by Time Magazine. She was inducted into the National Academy of Inventors in 2014, and was elected to the National Academy of Medicine in 2015. In April 2017, Dr. Niklason was also recognized by Fortune among a prestigious list of 34 leaders for driving impactful change in healthcare.

Dr. Niklason received her Ph.D. in Biophysics from the University of Chicago, and her M.D. from the University of Michigan. She completed her residency training in anesthesia and intensive care unit medicine at the Massachusetts General Hospital in Boston, and completed post-doctoral scientific training at Massachusetts Institute of Technology. Dr. Niklason is recognized as a global expert in cellular therapies and regenerative medicine. Today, she continues to teach, maintain a vigorous scientific laboratory, and speaks nationally and internationally on her research and exciting, emerging medical discoveries.